Non‐steroidal mineralocorticoid receptor antagonist vs selective aldosterone antagonist
Hyperkalaemia · proteinuric chronic kidney disease
Non‐steroidal mineralocorticoid receptor antagonist showed no clear difference in hyperkalaemia compared with selective aldosterone antagonist (low certainty).
1 finding from 1 review
- Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic… 2020 · Cochrane Headline outcomes onlyRR 0.89 [0.45, 1.77]1 study · 1023 participantsLow